Eterna Therapeutics Inc
Change company Symbol lookup
Select an option...
ERNA Eterna Therapeutics Inc
TANH Tantech Holdings Ltd
OMGA Omega Therapeutics Inc
INBS Intelligent Bio Solutions Inc
PAYX Paychex Inc
PYR Pyrogenesis Canada Inc
PM Philip Morris International Inc
GWAV Greenwave Technology Solutions Inc
SLNO Soleno Therapeutics Inc
VRPX Virpax Pharmaceuticals Inc

*Nasdaq FSI: *Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements

Health Care : Biotechnology | Small Cap Value
Company profile

Eterna Therapeutics Inc. is a preclinical-stage biopharmaceutical company. The Company is focused on developing advanced therapies using messenger ribonucleic acid (RNA) (mRNA) cell engineering technology. The Company has a portfolio of over 100 patents covering mRNA cell engineering technologies, including technologies for mRNA cell reprogramming, mRNA gene editing, the NoveSlice and UltraSlice gene-editing proteins, and the ToRNAdo mRNA delivery system, which the Company collectively refers to as its mRNA technology platform. Its mRNA gene-editing technology is designed to delete, insert, and repair deoxyribonucleic acid (DNA) sequences in living cells, which may be useful for correcting disease-causing mutations, making cells resistant to infection and degenerative disease, modulating the expression of immunoregulatory proteins to enable the generation of durable allogeneic cell therapies, and engineering immune cells to fight cancer.

Closing Price
Day's Change
0.04 (1.91%)
B/A Size
Day's High
Day's Low

10-day average volume:

PayPal Holdings Inc. Stock Falls Tuesday, Underperforms Market

5:21 pm ET May 16, 2023 (MarketWatch)

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of PayPal Holdings Inc. (PYPL) slid 2.33% to $60.80 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index falling 0.64% to 4,109.90 and Dow Jones Industrial Average falling 1.01% to 33,012.14.

PayPal Holdings Inc. closed $42.23 below its 52-week high ($103.03), which the company achieved on August 16th.

The stock underperformed when compared to some of its competitors Tuesday, as Apple Inc. (AAPL) remained unchanged, Alphabet Inc. Cl C (GOOGL) rose 2.68% to $120.09, and Alphabet Inc. Cl A (GOOGL) rose 2.57% to $119.51.

Trading volume (17.4 M) eclipsed its 50-day average volume of 14.0 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 16, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.


(END) Dow Jones Newswires

May 16, 2023 17:21 ET (21:21 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.